recent publications

• academic article

  • Gach, J. S., Quendler, H., Tong, T., Narayan, K. M., Du, S. X., Whalen, R. G., Binley, J. M., Forthal, D. N., Poignard, P., Zwick, M. B. A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1 PLoS One  2013 8:e72054  DOI:10.1371/journal.pone.0072054  PMID:23991039  PMCID:PMC3753353
  • Jaworski, J. P., Kobie, J., Brower, Z., Malherbe, D. C., Landucci, G., Sutton, W. F., Guo, B. W., Reed, J. S., Leon, E. J., Engelmann, F., Zheng, B., Legasse, A., et al. Neutralizing Polyclonal IgG Present during Acute Infection Prevents Rapid Disease Onset in Simian-Human Immunodeficiency Virus SHIVSF162P3-Infected Infant Rhesus Macaques Journal of Virology  2013 87:10447-10459  DOI:10.1128/jvi.00049-13  PMID:23885083
  • Gupta, S., Gach, J. S., Becerra, J. C., Phan, T. B., Pudney, J., Moldoveanu, Z., Joseph, S. B., Landucci, G., Supnet, M. J., Ping, L. H., Corti, D., Moldt, B., et al. The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells PLoS Pathogens  2013 9:e1003776  DOI:10.1371/journal.ppat.1003776  PMID:24278022  PMCID:PMC3836734
  • Moldt, B., Shibata-Koyama, M., Rakasz, E. G., Schultz, N., Kanda, Y., Dunlop, D. C., Finstad, S. L., Jin, C. G., Landucci, G., Alpert, M. D., Dugast, A. S., Parren, Pwhi, et al. A nonfucosylated variant of the anti-hiv-1 monoclonal antibody b12 has enhanced fc gamma riiia-mediated antiviral activity in vitro but does not improve protection against mucosal shiv challenge in macaques Journal of Virology  2012 86:6189-6196  DOI:10.1128/jvi.00491-12  PMID:22457527  PMCID:PMC3372207
  • Hessell, A. J., Rakasz, E. G., Tehrani, D. M., Huber, M., Weisgrau, K. L., Landucci, G., Forthal, D. N., Koff, W. C., Poignard, P., Watkins, D. I., Burton, D. R. Broadly neutralizing monoclonal antibodies 2f5 and 4e10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus shivba-l Journal of Virology  2010 84:1302-1313  DOI:10.1128/jvi.01272-09  PMID:19906907  PMCID:PMC2812338
  • Ng, C. T., Jaworski, J. P., Jayaraman, P., Sutton, W. F., Delio, P., Kuller, L., Anderson, D., Landucci, G., Richardson, B. A., Burton, D. R., Forthal, D. N., Haigwood, N. L. Passive neutralizing antibody controls shiv viremia and enhances b cell responses in infant macaques Nature Medicine  2010 16:1117-1119  DOI:10.1038/nm.2233  PMID:20890292  PMCID:PMC2952052
  • Hessell, A. J., Rakasz, E. G., Poignard, P., Hangartner, L., Landucci, G., Forthal, D. N., Koff, W. C., Watkins, D. I., Burton, D. R. Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers PLoS Pathogens  2009 5:e1000433  DOI:10.1371/journal.ppat.1000433  PMID:19436712  PMCID:PMC2674935
  • Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, Pwhi, Marx, P. A., Burton, D. R. Fc receptor but not complement binding is important in antibody protection against HIV Nature  2007 449:101-104  DOI:10.1038/nature06106  PMID:17805298
  • Manchester, M., Eto, D. S., Valsamakis, A., Liton, P. B., Fernandez-Munoz, R., Rota, P. A., Bellini, W. J., Forthal, D. N., Oldstone, M. B. A. Clinical isolates of measles virus use cd46 as a cellular receptor? Journal of Virology  2000 74:3967-3974  DOI:10.1128/jvi.74.9.3967-3974.2000  PMID:10756008